The Found Script
Go beyond finding medications. Expert guides, shortage updates, and tips for navigating the healthcare system.
Nitrostat Shortage: What Providers and Prescribers Need to Know in 2026
A clinical guide for providers on Nitrostat (nitroglycerin sublingual) availability in 2026: shortage status, formulary considerations, and patient communication strategies.
Nizatidine Shortage: What Providers and Prescribers Need to Know in 2026
A clinical guide for prescribers on nizatidine availability in 2026 — including the NDMA recall history, therapeutic substitution options, and how to help your patients find it.
Nonoxynol-9 Shortage: What Providers and Prescribers Need to Know in 2026
A provider-focused update on nonoxynol-9 spermicide availability in 2026, including OTC market dynamics, patient counseling strategies, and evidence-based alternatives.
Nortriptyline Shortage: What Providers and Prescribers Need to Know in 2026
Nortriptyline is not in a national shortage in 2026, but providers should know the supply landscape, pharmacogenomic considerations, and how to help patients find it.
37,000+ have already found their meds with Medfinder.
Stop calling pharmacies. Start your search today.
NovoEight Shortage: What Providers and Prescribers Need to Know in 2026
A clinical overview for hematologists and HTC providers on NovoEight availability in 2026, specialty pharmacy distribution, formulary dynamics, and patient access strategies.
Onfi Shortage: What Providers and Prescribers Need to Know in 2026
A clinical briefing for neurologists and prescribers on the Onfi (clobazam) shortage in 2026: supply landscape, clinical risks, therapeutic alternatives, and patient support tools.
Opill 28 Day Shortage: What Providers and Prescribers Need to Know in 2026
Opill is widely available OTC but patients still encounter access barriers. Here's what clinicians need to know about Opill availability, coverage gaps, and counseling patients in 2026.
Outgro Pain Relief Shortage: What Providers and Prescribers Need to Know in 2026
Outgro Pain Relief has largely disappeared from retail. Providers should know the clinical context, FDA history, and how to guide patients toward appropriate OTC alternatives.
Oxtellar XR Shortage: What Providers and Prescribers Need to Know in 2026
A clinical overview for neurologists, epileptologists, and PCPs on Oxtellar XR availability challenges in 2026, including patient access strategies and alternative options.
Paragard Shortage: What Providers and Prescribers Need to Know in 2026
Paragard access challenges in 2026 are real, even without a formal FDA shortage. Here's what prescribers need to know about availability, litigation, and patient counseling.
Paromomycin Shortage: What Providers and Prescribers Need to Know in 2026
The paromomycin generic was discontinued in 2021. Here's a clinical guide for providers on supply status, alternatives, prior auth, and patient assistance in 2026.
Paxil Shortage: What Providers and Prescribers Need to Know in 2026
A clinical overview of paroxetine availability in 2026 for providers: which formulations are at risk, how to manage patient supply issues, and when to consider alternatives.